{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=completion_date&start=35700","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=completion_date&start=35100","results":[{"registry_id":"NCT06991127","publication_url":"https://clinicaltrials.gov/study/NCT06991127","title":"Pre-market Multicentric Cross-sectional Clinical Investigation of MAIA Microperimeter Device: Mesopic Normative Database Collection","has_exemption":false,"start_date":"2025-04-23","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Centervue SpA","sponsor_slug":"centervue-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06709573","publication_url":"https://clinicaltrials.gov/study/NCT06709573","title":"Clinical Decision Support Assistance to Randomize Patients to Early or Late Adjunctive Vasopressin in Septic Shock","has_exemption":false,"start_date":"2025-04-29","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06865469","publication_url":"https://clinicaltrials.gov/study/NCT06865469","title":"Comparing Efficacy of Intravenous Dexmedetomidine and Lidocaine on Postoperative Analgesia in Patients Undergoing Fracture Hip Surgery","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919796","publication_url":"https://clinicaltrials.gov/study/NCT06919796","title":"Systems Biology of a mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Given Via Intradermal (ID) Injection Using Tropis Needle-Free Injection System (NFIS) or Intramuscular (IM) Injection Using Needle and Syringe","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"PharmaJet, Inc.","sponsor_slug":"pharmajet-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937385","publication_url":"https://clinicaltrials.gov/study/NCT06937385","title":"Randomized, Prospective, Open-label, Controlled Trial of 0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications in Treatment of Non-Traumatic Headache in the Emergency Department","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"HCA Florida North Florida Hospital","sponsor_slug":"hca-florida-north-florida-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06955559","publication_url":"https://clinicaltrials.gov/study/NCT06955559","title":"Magnesium Sulfate in Bronchial Asthma and Acute Bronchiolitis in Children","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953271","publication_url":"https://clinicaltrials.gov/study/NCT06953271","title":"Methenamine Hippurate Compared to Typical Antibiotic Prophylaxis in the Prevention of Urinary Tract Infection Following Intradetrusor OnabotulinumtoxinA Injection for Treatment of Overactive Bladder: a Randomized Controlled Non-Inferiority Trial","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06896903","publication_url":"https://clinicaltrials.gov/study/NCT06896903","title":"Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing","has_exemption":false,"start_date":"2025-05-21","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540312","publication_url":"https://clinicaltrials.gov/study/NCT07540312","title":"A Prospective Interventional Trial With a Non-invasive Variable Compression System (VCS) to Determine the Efficacy in Patients With Moderate to Severe Irritable Bowel Syndrome (IBS)","has_exemption":false,"start_date":"2025-05-21","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"PGP Health","sponsor_slug":"pgp-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596655","publication_url":"https://clinicaltrials.gov/study/NCT06596655","title":"Implementation of Low-Cost Single-Use Flexible Bronchoscopes for Routine Interventional Pulmonary Procedures: A Feasibility Study","has_exemption":false,"start_date":"2025-05-23","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698627","publication_url":"https://clinicaltrials.gov/study/NCT06698627","title":"IMPRIVE Pilot Study: Comparison of Two Over the Counter Intravaginal Devices for the Treatment of Stress Urinary Incontinence","has_exemption":false,"start_date":"2025-06-30","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07038070","publication_url":"https://clinicaltrials.gov/study/NCT07038070","title":"A Randomized Controlled Trial Comparing the Efficacy of Topical Vaginal Estrogen Versus Topical Vaginal Estrogen Plus Via, a Hyaluronic Acid-Based Vaginal Moisturizer, in the Treatment of Genitourinary Syndrome of Menopause","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07052721","publication_url":"https://clinicaltrials.gov/study/NCT07052721","title":"A Randomized, Single-Blinded, Sham-Controlled Study Evaluating the Efficacy and Safety of RELAY, a Device Enabling Both Local Anesthetic Delivery and Neuromodulation Following Shoulder or Foot Surgery","has_exemption":false,"start_date":"2025-09-05","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217691","publication_url":"https://clinicaltrials.gov/study/NCT07217691","title":"Optimization of Commissural Alignment During Transcatheter Aortic Valve Implantation With Evolut FX+. A Randomized, Prospective Study.","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Oslo University Hospital","sponsor_slug":"oslo-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07440303","publication_url":"https://clinicaltrials.gov/study/NCT07440303","title":"The Clinical Efficacy of Star Matrix Versus Autogenous Gingival Graft in Augmenting Keratinized Tissue Around Teeth- A Split-mouth Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2025-11-06","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Harvard Medical School (HMS and HSDM)","sponsor_slug":"harvard-medical-school-hms-and-hsdm","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220005","publication_url":"https://clinicaltrials.gov/study/NCT07220005","title":"Low Intensity Focused Ultrasound Stimulation in Stroke Patients - Parameter Optimization","has_exemption":false,"start_date":"2025-12-10","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810310","publication_url":"https://clinicaltrials.gov/study/NCT06810310","title":"Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder","has_exemption":false,"start_date":"2025-12-22","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"Anna Rose Childress, Ph.D.","sponsor_slug":"anna-rose-childress-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07363421","publication_url":"https://clinicaltrials.gov/study/NCT07363421","title":"Feasibility Study Protocol: TMS-Induced LH Response in Healthy Women in the Luteal Phase","has_exemption":false,"start_date":"2026-02-24","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"The City College of New York","sponsor_slug":"the-city-college-of-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07240818","publication_url":"https://clinicaltrials.gov/study/NCT07240818","title":"Tissue Sample Comparison Between 22G FNB Needle and a New EUS Core Needle Biopsy Device for Pancreatic Lesions: A Single Center Prospective Randomized Pilot Trial","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06011187","publication_url":"https://clinicaltrials.gov/study/NCT06011187","title":"\"Personalized Fluid Administration Using an AFM System for Goal Directed Fluid Therapy on Postoperative Outcome in High-risk Patients Undergoing High-risk Abdominal Surgery: A Multicenter Stepped-wedge, Cluster-randomized Clinical Trial","has_exemption":false,"start_date":"2024-02-01","completion_date":"2026-05-02","has_results":false,"results_due":false,"sponsor_name":"Assistance Publique - Hôpitaux de Paris","sponsor_slug":"assistance-publique-hopitaux-de-paris","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02235857","publication_url":"https://clinicaltrials.gov/study/NCT02235857","title":"Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 System","has_exemption":false,"start_date":"2015-05-03","completion_date":"2026-05-03","has_results":false,"results_due":false,"sponsor_name":"Kaneka Medical America LLC","sponsor_slug":"kaneka-medical-america-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04650568","publication_url":"https://clinicaltrials.gov/study/NCT04650568","title":"A Prospective Randomized Trial of Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction","has_exemption":false,"start_date":"2017-11-03","completion_date":"2026-05-03","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04878094","publication_url":"https://clinicaltrials.gov/study/NCT04878094","title":"ARIA II: A Phase III Randomized Controlled Trial of Near-Infrared Angiography During Rectosigmoid Resection and Anastomosis in Women With Ovarian Cancer","has_exemption":false,"start_date":"2021-05-03","completion_date":"2026-05-03","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06610448","publication_url":"https://clinicaltrials.gov/study/NCT06610448","title":"Wearable Evaluation of Ambulatory Readings for Blood Pressure","has_exemption":false,"start_date":"2025-06-06","completion_date":"2026-05-03","has_results":false,"results_due":false,"sponsor_name":"Stephen Juraschek","sponsor_slug":"stephen-juraschek","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07434271","publication_url":"https://clinicaltrials.gov/study/NCT07434271","title":"Explorative Double-Blind Placebo Controlled Crossover Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-05-03","has_results":false,"results_due":false,"sponsor_name":"Kadence Bio","sponsor_slug":"kadence-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04248439","publication_url":"https://clinicaltrials.gov/study/NCT04248439","title":"A Phase 2 Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Pediatric Subjects With Fanconi Anemia Subtype A","has_exemption":false,"start_date":"2020-07-15","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Rocket Pharmaceuticals Inc.","sponsor_slug":"rocket-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327127","publication_url":"https://clinicaltrials.gov/study/NCT05327127","title":"Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Participants With Noncirrhotic Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis","has_exemption":false,"start_date":"2022-11-14","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Kowa Research Institute, Inc.","sponsor_slug":"kowa-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07031206","publication_url":"https://clinicaltrials.gov/study/NCT07031206","title":"Investigating Pre-Procedural Anxiety and Effect of Analgesia on Intrauterine Device Placement and Endometrial Biopsy","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07069309","publication_url":"https://clinicaltrials.gov/study/NCT07069309","title":"A Phase 3 Protocol to Investigate the Safety, Tolerability, and Immunogenicity of BNT162b2 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants 12 Through 64 Years of Age Considered at Higher Risk of Severe COVID-19, and Participants ≥65 Years of Age","has_exemption":false,"start_date":"2025-07-08","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07027267","publication_url":"https://clinicaltrials.gov/study/NCT07027267","title":"A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Effectiveness of TurbAlign™ to Achieve Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery (FESS) (GAIA)","has_exemption":false,"start_date":"2025-08-04","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Spirair, Inc","sponsor_slug":"spirair-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04764942","publication_url":"https://clinicaltrials.gov/study/NCT04764942","title":"Phase 1/2 Trial of Selinexor in Combination With Pomalidomide and Dexamethasone ± Carfilzomib for Patients With Proteasome-Inhibitor and Immunomodulatory Drug Refractory Multiple Myeloma (SCOPE)","has_exemption":false,"start_date":"2021-05-06","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05248646","publication_url":"https://clinicaltrials.gov/study/NCT05248646","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.","has_exemption":false,"start_date":"2022-03-15","completion_date":"2026-05-07","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06550076","publication_url":"https://clinicaltrials.gov/study/NCT06550076","title":"A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2024-09-04","completion_date":"2026-05-07","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220161","publication_url":"https://clinicaltrials.gov/study/NCT07220161","title":"Innovative Repurposing of Trigeminal Nerve Stimulation of the Treatment of Epilepsy in Veterans","has_exemption":false,"start_date":"2025-05-08","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06873789","publication_url":"https://clinicaltrials.gov/study/NCT06873789","title":"A Phase 1/2, Open-Label, Multicenter Study of INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-06-30","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05409976","publication_url":"https://clinicaltrials.gov/study/NCT05409976","title":"Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction","has_exemption":false,"start_date":"2022-10-25","completion_date":"2026-05-09","has_results":true,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06637514","publication_url":"https://clinicaltrials.gov/study/NCT06637514","title":"A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria","has_exemption":false,"start_date":"2025-07-16","completion_date":"2026-05-09","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07244913","publication_url":"https://clinicaltrials.gov/study/NCT07244913","title":"Therapeutic Effects of Instrument-assisted Versus Sound-assisted Soft Tissue Mobilization Among Patients With Chronic Non-specific Low Back Pain","has_exemption":false,"start_date":"2025-12-23","completion_date":"2026-05-09","has_results":false,"results_due":false,"sponsor_name":"University of Lahore","sponsor_slug":"university-of-lahore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06358313","publication_url":"https://clinicaltrials.gov/study/NCT06358313","title":"Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke, a Randomized Controlled Single-blinded Trial","has_exemption":false,"start_date":"2024-04-10","completion_date":"2026-05-10","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07089706","publication_url":"https://clinicaltrials.gov/study/NCT07089706","title":"A Phase 3b/4, Open-label Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Vaccine Formulations","has_exemption":false,"start_date":"2025-07-21","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07031336","publication_url":"https://clinicaltrials.gov/study/NCT07031336","title":"Photon-counting CT Post-processing Protocols for Robust Quantifications in Chest CT Scans","has_exemption":false,"start_date":"2025-11-14","completion_date":"2026-05-12","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03950076","publication_url":"https://clinicaltrials.gov/study/NCT03950076","title":"EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)","has_exemption":false,"start_date":"2019-09-20","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"Population Health Research Institute","sponsor_slug":"population-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04825743","publication_url":"https://clinicaltrials.gov/study/NCT04825743","title":"A Phase 3 Prospective, Blinded, Randomized, Placebo Controlled, International Multicenter Study to Assess the Safety and Efficacy of a Single SQ Injection of Zalunfiban in Subjects With ST-elevation MI in the Pre-hospital Setting","has_exemption":false,"start_date":"2021-04-24","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"CeleCor Therapeutics","sponsor_slug":"celecor-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702995","publication_url":"https://clinicaltrials.gov/study/NCT06702995","title":"A Phase Ib/II Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) Who Failed Prior Novel Hormone Therapy","has_exemption":false,"start_date":"2023-04-19","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"Evopoint Biosciences Inc.","sponsor_slug":"evopoint-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07141121","publication_url":"https://clinicaltrials.gov/study/NCT07141121","title":"Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02568267","publication_url":"https://clinicaltrials.gov/study/NCT02568267","title":"An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements","has_exemption":false,"start_date":"2015-11-19","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04519879","publication_url":"https://clinicaltrials.gov/study/NCT04519879","title":"A Randomized Phase 2 Trial of White Button Mushroom Supplement in Patients With Biochemically Recurrent Prostate Cancer Following Local Therapy and in Therapy Na?ve Patients With Favorable Risk Prostate Cancer Undergoing Active Surveillance","has_exemption":false,"start_date":"2021-05-10","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05399888","publication_url":"https://clinicaltrials.gov/study/NCT05399888","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease Dementia","has_exemption":false,"start_date":"2022-08-24","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05898399","publication_url":"https://clinicaltrials.gov/study/NCT05898399","title":"A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the DNA Polymerase Theta Inhibitor ART6043 Administered Orally as Monotherapy and in Combination to Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-06-30","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Artios Pharma Ltd","sponsor_slug":"artios-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06194825","publication_url":"https://clinicaltrials.gov/study/NCT06194825","title":"A Phase 3, Randomized Study, With Initial 24-week, Double-Blind and Placebo-Controlled Treatment Phase, Followed by An 80-week Open-label Extension Treatment Phase to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-Term Safety in Chinese Participants With Transthyretin Amyloid Cardiomyopathy (EPIC-ATTR)","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06346392","publication_url":"https://clinicaltrials.gov/study/NCT06346392","title":"A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared With Investigator's Choice of Therapy in Second- or Later-Line Adult Participants With Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 (CLARITY Gastric 01)","has_exemption":false,"start_date":"2024-03-04","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05218811","publication_url":"https://clinicaltrials.gov/study/NCT05218811","title":"Cryotherapy and Robotic Assisted Non Ischemic Nephron Sparring Surgery","has_exemption":false,"start_date":"2020-05-15","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Urological Research Network, LLC","sponsor_slug":"urological-research-network-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04655963","publication_url":"https://clinicaltrials.gov/study/NCT04655963","title":"Neuromodulation and Plasticity in Cognitive Control Neurocircuitry in Chronic Stroke","has_exemption":false,"start_date":"2021-01-14","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05280548","publication_url":"https://clinicaltrials.gov/study/NCT05280548","title":"A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared With Usual Standard of Care on Left Ventricular Mass Index in Participants With Fabry Disease and Left Ventricular Hypertrophy","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05143177","publication_url":"https://clinicaltrials.gov/study/NCT05143177","title":"An Adaptive Phase 2/3 Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel, 2 Arm Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"REDNVIA Co., Ltd.","sponsor_slug":"rednvia-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05382442","publication_url":"https://clinicaltrials.gov/study/NCT05382442","title":"A Phase II Study of AK112 With or Without AK117 for Patients With Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Akeso","sponsor_slug":"akeso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05731128","publication_url":"https://clinicaltrials.gov/study/NCT05731128","title":"A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Evaluate the Efficacy and Safety of Dupilumab Therapy in Patients With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05836571","publication_url":"https://clinicaltrials.gov/study/NCT05836571","title":"Randomized Phase 2 Study of Cabozantinib, Ipilimumab, and Nivolumab in Patients With Soft Tissue Sarcoma","has_exemption":false,"start_date":"2023-10-25","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute LAO","sponsor_slug":"national-cancer-institute-lao","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06560684","publication_url":"https://clinicaltrials.gov/study/NCT06560684","title":"A PHASE 2 CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR-BASED PREP EVALUATING EXTENDED SAFETY, ACCEPTABILITY, AND PHARMACOKINETICS/PHARMACODYNAMICS","has_exemption":false,"start_date":"2024-10-29","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810726","publication_url":"https://clinicaltrials.gov/study/NCT06810726","title":"EVALUATION OF THE SAFETY AND THE CLINICAL PERFORMANCE IN TREATMENT OF CHRONIC DIABETIC FOOT ULCER, WITH THE TROPOCELLS®, BASED AUTOLOGOUS PLATELET RICH FIBRIN (Tropocells(R) Autologous PRF Systems)","has_exemption":false,"start_date":"2025-04-15","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Estar Medical dba Medical Technologies, LTD","sponsor_slug":"estar-medical-dba-medical-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06981949","publication_url":"https://clinicaltrials.gov/study/NCT06981949","title":"The Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery - A Double-blinded Randomized Clinical Trial","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Lebanese American University","sponsor_slug":"lebanese-american-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07138560","publication_url":"https://clinicaltrials.gov/study/NCT07138560","title":"BOOST-PD - Better On-time Observations of Motor Fluctuations Using Wearable Sensor Technology: A Naturalistic Study on IPX-203 for Parkinson's Disease","has_exemption":false,"start_date":"2025-07-24","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07105254","publication_url":"https://clinicaltrials.gov/study/NCT07105254","title":"An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Derm Texas, PLLC","sponsor_slug":"derm-texas-pllc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07121192","publication_url":"https://clinicaltrials.gov/study/NCT07121192","title":"A Phase 2a Randomized, Observer-Blind, Study to Evaluate the Immunogenicity and Safety of mRNA-Based Multivalent Seasonal Influenza Vaccine Candidates in Adults 18 Years of Age And Older","has_exemption":false,"start_date":"2025-08-25","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07421544","publication_url":"https://clinicaltrials.gov/study/NCT07421544","title":"A Prospective, Phase 4, Multicenter, Open-label Pilot Study of Obagi® Saypha® MagIQ™ Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Goldman, Butterwick, Fitzpatrick and Groff","sponsor_slug":"goldman-butterwick-fitzpatrick-and-groff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07471750","publication_url":"https://clinicaltrials.gov/study/NCT07471750","title":"Acquisition and Clinical Image Evaluation of Fujifilm High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images","has_exemption":false,"start_date":"2026-03-30","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Fujifilm Medical Systems USA, Inc.","sponsor_slug":"fujifilm-medical-systems-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03718637","publication_url":"https://clinicaltrials.gov/study/NCT03718637","title":"Efficacy Evaluation of Surgical Treatment Using Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)","has_exemption":false,"start_date":"2019-04-17","completion_date":"2026-05-17","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05746559","publication_url":"https://clinicaltrials.gov/study/NCT05746559","title":"ARTEMIS: RAvulizumab to PRotect PaTients With Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study","has_exemption":false,"start_date":"2023-04-06","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03348670","publication_url":"https://clinicaltrials.gov/study/NCT03348670","title":"Explore the Relationship Between Single Nucleotide Polymorphisms and Abiraterone Response and Toxicity in Patients With Prostate Cancer.","has_exemption":false,"start_date":"2023-08-18","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair","sponsor_slug":"han-xu-md-phd-fapcr-sponsor-investigator-irb-chair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299098","publication_url":"https://clinicaltrials.gov/study/NCT06299098","title":"A Randomized, Double-Blind Study of The Efficacy and Safety of Trevogrumab, With or Without Garetosmab, in Addition to Semaglutide in Patients With Obesity","has_exemption":false,"start_date":"2024-03-13","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06444113","publication_url":"https://clinicaltrials.gov/study/NCT06444113","title":"A Phase IV, Prospective, Multicenter, Open-label, Mother-milk Study to Evaluate Ofatumumab Concentration in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis Receiving Ofatumumab","has_exemption":false,"start_date":"2024-11-25","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05405387","publication_url":"https://clinicaltrials.gov/study/NCT05405387","title":"A Randomized Phase 2 Trial Investigating the Impact of Budesonide Prophylaxis on Incidence of ≥ Grade 2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant","has_exemption":false,"start_date":"2023-05-03","completion_date":"2026-05-19","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04305054","publication_url":"https://clinicaltrials.gov/study/NCT04305054","title":"A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02B","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06472388","publication_url":"https://clinicaltrials.gov/study/NCT06472388","title":"Randomized Phase II Trial of Everolimus 5 mg vs 10 mg/Daily for Patients With Advanced Neuroendocrine Tumors","has_exemption":false,"start_date":"2024-04-24","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"AC Camargo Cancer Center","sponsor_slug":"ac-camargo-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06401707","publication_url":"https://clinicaltrials.gov/study/NCT06401707","title":"PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest","has_exemption":false,"start_date":"2024-05-20","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06426498","publication_url":"https://clinicaltrials.gov/study/NCT06426498","title":"Developing a Method of Adjusting the Strength of Transcranial Focused Ultrasound (tFUS) to Personalize Treatment.","has_exemption":false,"start_date":"2024-06-20","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04437498","publication_url":"https://clinicaltrials.gov/study/NCT04437498","title":"Non-Invasive Vagal Nerve Stimulation in Veterans With Mild Traumatic Brain Injury (mTBI)","has_exemption":false,"start_date":"2021-02-25","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05036226","publication_url":"https://clinicaltrials.gov/study/NCT05036226","title":"Combination of Autophagy Selective Therapeutics (COAST) in Advanced Solid Tumors or Relapsed Prostate Cancer, A Phase I/II Trial","has_exemption":false,"start_date":"2022-03-03","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574868","publication_url":"https://clinicaltrials.gov/study/NCT05574868","title":"Evaluation of the Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis for the Treatment of Patients With Erectile Dysfunction","has_exemption":false,"start_date":"2022-07-11","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"Rigicon, Inc.","sponsor_slug":"rigicon-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07055516","publication_url":"https://clinicaltrials.gov/study/NCT07055516","title":"A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes","has_exemption":false,"start_date":"2025-05-08","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"NodThera Limited","sponsor_slug":"nodthera-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04779320","publication_url":"https://clinicaltrials.gov/study/NCT04779320","title":"A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy","has_exemption":false,"start_date":"2022-02-10","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05076175","publication_url":"https://clinicaltrials.gov/study/NCT05076175","title":"A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis With an Inadequate Response to Conventional Therapy","has_exemption":false,"start_date":"2022-05-30","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05364762","publication_url":"https://clinicaltrials.gov/study/NCT05364762","title":"Single Center Pilot Study to Investigate the Efficacy of Adding Itacitinib to Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning Matched Donor Hematopoietic Cell Transplantation With Peripheral Blood Stem Cells as Graft Source","has_exemption":false,"start_date":"2022-11-23","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05817812","publication_url":"https://clinicaltrials.gov/study/NCT05817812","title":"A Phase 3b Open-label Study Evaluating Physical Activity and Joint Health in Previously Treated Patients ≥12 Years With Severe Haemophilia A Treated With Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (Efanesoctocog Alfa) for 24 Months","has_exemption":false,"start_date":"2023-07-31","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Swedish Orphan Biovitrum","sponsor_slug":"swedish-orphan-biovitrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996471","publication_url":"https://clinicaltrials.gov/study/NCT05996471","title":"A Phase 2b Multicenter, Randomized, Open-Label Study Comparing the Efficacy, Safety, PK, and Tolerability of VH3810109, Administered Either Intravenously Or As A Subcutaneous Infusion With rHuPH20, in Combination With CAB LA to Standard of Care in Virologically Suppressed Adults Living With HIV","has_exemption":false,"start_date":"2023-08-17","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976243","publication_url":"https://clinicaltrials.gov/study/NCT05976243","title":"A 52-week Multi-center, Randomized, Double-blind, Placebo Controlled, Basket Study With an Open-label Extension to Investigate the Efficacy, Safety, and Tolerability of Remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in Adults Inadequately Controlled by H1-antihistamines","has_exemption":false,"start_date":"2023-12-07","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07443215","publication_url":"https://clinicaltrials.gov/study/NCT07443215","title":"Evaluation of Effect of Scatter on Visual Performance","has_exemption":false,"start_date":"2026-02-13","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06182124","publication_url":"https://clinicaltrials.gov/study/NCT06182124","title":"A Phase 1/2, Randomized, Double-Blind Trial of the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 18 Years of Age and Older","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-23","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06297265","publication_url":"https://clinicaltrials.gov/study/NCT06297265","title":"Feasibility and Effects of Manual Lymphatic Drainage (MLD) Breast Massage in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy","has_exemption":false,"start_date":"2024-05-24","completion_date":"2026-05-24","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04009499","publication_url":"https://clinicaltrials.gov/study/NCT04009499","title":"A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis","has_exemption":false,"start_date":"2019-08-13","completion_date":"2026-05-25","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06241118","publication_url":"https://clinicaltrials.gov/study/NCT06241118","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 3-arm, Multinational, Multicenter Study to Evaluate the Efficacy and Safety of Amlitelimab by Subcutaneous Injection in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (AD) Who Are on Background Topical Corticosteroids and Have Had an Inadequate Response to Prior Biologic Therapy or Oral Janus Kinase (JAK) Inhibitor Treatment","has_exemption":false,"start_date":"2024-02-29","completion_date":"2026-05-25","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06862791","publication_url":"https://clinicaltrials.gov/study/NCT06862791","title":"A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight With Co-morbidity (ASCEND)","has_exemption":false,"start_date":"2025-02-18","completion_date":"2026-05-25","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727578","publication_url":"https://clinicaltrials.gov/study/NCT06727578","title":"A Pilot Assessment of the Safety and Efficacy of Pleural Irrigation for Retained Pleural Infection Using a Novel Irrigation Device","has_exemption":false,"start_date":"2025-05-25","completion_date":"2026-05-25","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02094794","publication_url":"https://clinicaltrials.gov/study/NCT02094794","title":"Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) Given in Combination With Cyclophosphamide and Etoposide as Conditioning for Allogeneic (HSCT) in Patients With High-Risk Acute Lymphocytic or Myelogenous Leukemia","has_exemption":false,"start_date":"2014-05-12","completion_date":"2026-05-26","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04458610","publication_url":"https://clinicaltrials.gov/study/NCT04458610","title":"BTK Inhibitor Zanubrutinib (BGB-3111) in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)","has_exemption":false,"start_date":"2020-05-26","completion_date":"2026-05-26","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05376878","publication_url":"https://clinicaltrials.gov/study/NCT05376878","title":"Pilot Study to Evaluate 64Cu-DOTA-Trastuzumab Imaging in Patients With HER2+ Breast Cancer With Brain Metastatsis Treated With Fam-Trastuzumab Deruxtecan","has_exemption":false,"start_date":"2022-12-21","completion_date":"2026-05-26","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04342429","publication_url":"https://clinicaltrials.gov/study/NCT04342429","title":"RAD4649-19: Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer","has_exemption":false,"start_date":"2020-03-19","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05094336","publication_url":"https://clinicaltrials.gov/study/NCT05094336","title":"A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Anvumetostat Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors","has_exemption":false,"start_date":"2022-02-01","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06047457","publication_url":"https://clinicaltrials.gov/study/NCT06047457","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Episodic Migraine in Adult Participants","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06047444","publication_url":"https://clinicaltrials.gov/study/NCT06047444","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Chronic Migraine in Adult Participants","has_exemption":false,"start_date":"2023-10-12","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06143046","publication_url":"https://clinicaltrials.gov/study/NCT06143046","title":"A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Pregnant Women, and Safety and Immunogenicity in Infants Born to Vaccinated Mothers","has_exemption":false,"start_date":"2023-11-15","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06878404","publication_url":"https://clinicaltrials.gov/study/NCT06878404","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-naïve Participants With Active Psoriatic Arthritis","has_exemption":false,"start_date":"2025-02-21","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06851858","publication_url":"https://clinicaltrials.gov/study/NCT06851858","title":"A Phase II Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist","has_exemption":false,"start_date":"2025-03-12","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04055649","publication_url":"https://clinicaltrials.gov/study/NCT04055649","title":"Phase II Study of ONC201 Plus Weekly Paclitaxel in Patients With Platinum-Resistant Refractory or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","has_exemption":false,"start_date":"2020-01-21","completion_date":"2026-05-28","has_results":false,"results_due":false,"sponsor_name":"Ira Winer","sponsor_slug":"ira-winer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04916249","publication_url":"https://clinicaltrials.gov/study/NCT04916249","title":"Tibetree Pain-Relieving Plaster for Musculoskeletal Pain Among Cancer Survivors","has_exemption":false,"start_date":"2021-05-28","completion_date":"2026-05-28","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03847428","publication_url":"https://clinicaltrials.gov/study/NCT03847428","title":"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation","has_exemption":false,"start_date":"2019-04-29","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05791201","publication_url":"https://clinicaltrials.gov/study/NCT05791201","title":"A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus","has_exemption":false,"start_date":"2023-05-16","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05746572","publication_url":"https://clinicaltrials.gov/study/NCT05746572","title":"A Pilot Study of MDMA-Assisted Massed Exposure Therapy for PTSD (MDMA PE)","has_exemption":false,"start_date":"2024-02-13","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06532032","publication_url":"https://clinicaltrials.gov/study/NCT06532032","title":"A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Docetaxel Combination Therapy in Metastatic Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2024-07-23","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712407","publication_url":"https://clinicaltrials.gov/study/NCT06712407","title":"An Open-label Study to Assess the Efficacy and Safety of Extended TARPEYO® (Delayed-release Budesonide Capsules) Treatment in Adult Patients With Primary IgA Nephropathy Who Have Completed 9 Months of TARPEYO® 16 mg Once Daily Treatment in Real-world Clinical Practice","has_exemption":false,"start_date":"2024-12-17","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Calliditas Therapeutics AB","sponsor_slug":"calliditas-therapeutics-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533449","publication_url":"https://clinicaltrials.gov/study/NCT06533449","title":"Development of the Couplet Care Bassinet to Support Safe Implementation of Skin-to-skin Contact and rooming-in on Postnatal Units","has_exemption":false,"start_date":"2025-01-09","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05569239","publication_url":"https://clinicaltrials.gov/study/NCT05569239","title":"Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of One Dose of OVX836 Influenza Vaccine 480μg, After Intramuscular Administration in Healthy Subjects Aged 18-59 Years","has_exemption":false,"start_date":"2025-09-08","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Osivax","sponsor_slug":"osivax","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07207408","publication_url":"https://clinicaltrials.gov/study/NCT07207408","title":"Phase 2, Randomized, Multicenter Trial of the Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age","has_exemption":false,"start_date":"2025-09-11","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Dynavax Technologies Corporation","sponsor_slug":"dynavax-technologies-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286344","publication_url":"https://clinicaltrials.gov/study/NCT07286344","title":"Effect of Fluoride Varnish Formulation on the Management of Dentin Hypersensitivity: A Randomized Clinical Trial","has_exemption":false,"start_date":"2025-12-04","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"University of Concepcion, Chile","sponsor_slug":"university-of-concepcion-chile","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02710253","publication_url":"https://clinicaltrials.gov/study/NCT02710253","title":"Phase II Trial of Salvage Radiation Therapy to Induce Systemic Disease Regression After Progression on Systemic Immunotherapy","has_exemption":false,"start_date":"2016-05-25","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03194893","publication_url":"https://clinicaltrials.gov/study/NCT03194893","title":"A Multicenter, International, Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer","has_exemption":false,"start_date":"2017-07-05","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03600883","publication_url":"https://clinicaltrials.gov/study/NCT03600883","title":"A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)","has_exemption":false,"start_date":"2018-08-27","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03996265","publication_url":"https://clinicaltrials.gov/study/NCT03996265","title":"Randomized Placebo Controlled Trial of Bupropion For Cancer Related Fatigue","has_exemption":false,"start_date":"2019-06-27","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Rochester NCORP Research Base","sponsor_slug":"university-of-rochester-ncorp-research-base","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128670","publication_url":"https://clinicaltrials.gov/study/NCT04128670","title":"Effects of Kinesio Tape on Delayed Onset Muscle Soreness","has_exemption":false,"start_date":"2020-01-30","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04396821","publication_url":"https://clinicaltrials.gov/study/NCT04396821","title":"A Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of TST001 Administered as Monotherapy or in Combination With Nivolumab or Standard of Care in Patients With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-05-28","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Suzhou Transcenta Therapeutics Co., Ltd.","sponsor_slug":"suzhou-transcenta-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04408313","publication_url":"https://clinicaltrials.gov/study/NCT04408313","title":"A Comparative Effectiveness Trial of Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail","has_exemption":false,"start_date":"2020-10-28","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Friends Research Institute, Inc.","sponsor_slug":"friends-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04558164","publication_url":"https://clinicaltrials.gov/study/NCT04558164","title":"Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment","has_exemption":false,"start_date":"2021-01-26","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04090424","publication_url":"https://clinicaltrials.gov/study/NCT04090424","title":"A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries","has_exemption":false,"start_date":"2021-09-21","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"PolyNovo Biomaterials Pty Ltd.","sponsor_slug":"polynovo-biomaterials-pty-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05097976","publication_url":"https://clinicaltrials.gov/study/NCT05097976","title":"An Oral Methylprednisolone Taper Within a Multimodal Analgesic Regimen After Total Knee Arthroplasty: a Double-Blind Randomized Placebo-Controlled Trial","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159595","publication_url":"https://clinicaltrials.gov/study/NCT06159595","title":"Behavioral and Neuronal Correlates of Human Mood States","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214923","publication_url":"https://clinicaltrials.gov/study/NCT06214923","title":"Neural Mechanisms of Immersive Virtual Reality in Chronic Pain","has_exemption":false,"start_date":"2024-04-09","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06464107","publication_url":"https://clinicaltrials.gov/study/NCT06464107","title":"Endometrial Cancer Cell Collection With the Preprogen PadKit™","has_exemption":false,"start_date":"2024-05-31","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455098","publication_url":"https://clinicaltrials.gov/study/NCT06455098","title":"Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation With the BWI Pulsed Field Ablation System With OMNYPULSE™ Catheter","has_exemption":false,"start_date":"2024-06-28","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06189703","publication_url":"https://clinicaltrials.gov/study/NCT06189703","title":"tRNS Treatment for ADHD Symptoms","has_exemption":false,"start_date":"2024-07-15","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Innosphere","sponsor_slug":"innosphere","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06321471","publication_url":"https://clinicaltrials.gov/study/NCT06321471","title":"AeviceMD for Pediatric Asthma Management","has_exemption":false,"start_date":"2024-11-05","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Irina Dralyuk","sponsor_slug":"irina-dralyuk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827977","publication_url":"https://clinicaltrials.gov/study/NCT06827977","title":"A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis","has_exemption":false,"start_date":"2025-03-03","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06446765","publication_url":"https://clinicaltrials.gov/study/NCT06446765","title":"Mindfulness-based Neurofeedback to Augment Dialectical Behavior Therapy (DBT) for Adults With Borderline Personality Disorder (Aim 1)","has_exemption":false,"start_date":"2025-03-13","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342413","publication_url":"https://clinicaltrials.gov/study/NCT07342413","title":"A Single-center Prospective Double-Blind, Split-Body, Randomized Clinical Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias","has_exemption":false,"start_date":"2026-02-01","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Goldman, Butterwick, Fitzpatrick and Groff","sponsor_slug":"goldman-butterwick-fitzpatrick-and-groff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00492999","publication_url":"https://clinicaltrials.gov/study/NCT00492999","title":"A Phase II Study of the Rate of Conversion to Complete Resection in Patients With Initially Inoperable Hepatic-Only Metastases From Colorectal Cancer After Treatment With Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Best Systemic Chemotherapy","has_exemption":false,"start_date":"2007-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00911560","publication_url":"https://clinicaltrials.gov/study/NCT00911560","title":"Phase I/II Trial of a Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma","has_exemption":false,"start_date":"2009-05-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01370512","publication_url":"https://clinicaltrials.gov/study/NCT01370512","title":"Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension","has_exemption":false,"start_date":"2011-11-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01868451","publication_url":"https://clinicaltrials.gov/study/NCT01868451","title":"A Pilot Study of Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma","has_exemption":false,"start_date":"2013-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02141919","publication_url":"https://clinicaltrials.gov/study/NCT02141919","title":"A Phase II Trial of Stereotactic Ablative Body Radiation Therapy (SABR) for Patients With Primary Renal Cancer (RCC)","has_exemption":false,"start_date":"2013-06-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02422641","publication_url":"https://clinicaltrials.gov/study/NCT02422641","title":"Traditional Incision and Drainage of Cutaneous Abscess Vs. Minimally Invasive Incision and Drainage With Vessel Loop: A Randomized Controlled Trail","has_exemption":false,"start_date":"2015-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02450708","publication_url":"https://clinicaltrials.gov/study/NCT02450708","title":"Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes","has_exemption":false,"start_date":"2015-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02451982","publication_url":"https://clinicaltrials.gov/study/NCT02451982","title":"A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients With Surgically Resectable Adenocarcinoma of the Pancreas","has_exemption":false,"start_date":"2016-03-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02127398","publication_url":"https://clinicaltrials.gov/study/NCT02127398","title":"Fecal Microbiota Transplantation in Refractory Clostridium Difficile Colitis","has_exemption":false,"start_date":"2016-04-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02750358","publication_url":"https://clinicaltrials.gov/study/NCT02750358","title":"Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR(+) Triple Negative Breast Cancer","has_exemption":false,"start_date":"2016-05-19","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02780310","publication_url":"https://clinicaltrials.gov/study/NCT02780310","title":"A Phase II Study of Lenvatinib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma","has_exemption":false,"start_date":"2016-05-19","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02653755","publication_url":"https://clinicaltrials.gov/study/NCT02653755","title":"The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer","has_exemption":false,"start_date":"2016-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02755272","publication_url":"https://clinicaltrials.gov/study/NCT02755272","title":"A Randomized Phase II Clinical Trial Assessing the Efficacy and Safety of MK-3475 (Pembrolizumab) in Combination With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2016-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03206502","publication_url":"https://clinicaltrials.gov/study/NCT03206502","title":"Characterizing Sleep, Stress, and Seizures in Daily Life: An Internet-based Study With the Empatica Embrace Watch and Smartphone-based Diary-alert System","has_exemption":false,"start_date":"2016-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Empatica, Inc.","sponsor_slug":"empatica-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02954874","publication_url":"https://clinicaltrials.gov/study/NCT02954874","title":"A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2017-01-18","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03121001","publication_url":"https://clinicaltrials.gov/study/NCT03121001","title":"A Phase II Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease","has_exemption":false,"start_date":"2017-03-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03222531","publication_url":"https://clinicaltrials.gov/study/NCT03222531","title":"Expanding the Pool in Orthotopic Heart Transplantation: The Use of Hepatitis C Positive Donor Hearts in Hepatitis C Negative Recipients","has_exemption":false,"start_date":"2017-08-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Mary E. Keebler, MD","sponsor_slug":"mary-e-keebler-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03192020","publication_url":"https://clinicaltrials.gov/study/NCT03192020","title":"DupuytrEn Treatment EffeCtiveness Trial (DETECT): Needle Fasciotomy, Surgery or Collagenase Injection for Dupuytren's Contracture","has_exemption":false,"start_date":"2017-09-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Tampere University","sponsor_slug":"tampere-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03201094","publication_url":"https://clinicaltrials.gov/study/NCT03201094","title":"Impact of Neuromuscular Stimulation and High Protein Nutritional Supplementation on Long-term Recovery After Aneurysmal Subarachnoid Hemorrhage.","has_exemption":false,"start_date":"2017-12-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03331380","publication_url":"https://clinicaltrials.gov/study/NCT03331380","title":"Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System","has_exemption":false,"start_date":"2018-01-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03040778","publication_url":"https://clinicaltrials.gov/study/NCT03040778","title":"Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment","has_exemption":false,"start_date":"2018-04-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03105102","publication_url":"https://clinicaltrials.gov/study/NCT03105102","title":"A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease","has_exemption":false,"start_date":"2018-04-09","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03506334","publication_url":"https://clinicaltrials.gov/study/NCT03506334","title":"Prospective Pilot Study of Anterior Vertebral Body Tethering Using Zimmer Biomet Tether System or Dynesys System Components to Treat Pediatric Scoliosis","has_exemption":false,"start_date":"2018-04-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03510208","publication_url":"https://clinicaltrials.gov/study/NCT03510208","title":"Phase I/II, Open-Label Study Evaluating the Efficacy and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms During Neurosurgical Procedures","has_exemption":false,"start_date":"2018-05-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04096170","publication_url":"https://clinicaltrials.gov/study/NCT04096170","title":"Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo","has_exemption":false,"start_date":"2018-06-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03729518","publication_url":"https://clinicaltrials.gov/study/NCT03729518","title":"A Phase II Study of Volume and Dose De-Intensification Following Transoral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma","has_exemption":false,"start_date":"2018-10-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03632044","publication_url":"https://clinicaltrials.gov/study/NCT03632044","title":"Evaluation of Trigeminal Nerve Blockade in the Pterygopalatine Fossa for Cleft Palate Repair: a Pilot Study","has_exemption":false,"start_date":"2018-11-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03598595","publication_url":"https://clinicaltrials.gov/study/NCT03598595","title":"A Phase 1/2 Study of Gemcitabine and Docetaxel in Combination With Hydroxychloroquine (Autophagy Inhibitor) in Patients With Recurrent Osteosarcoma","has_exemption":false,"start_date":"2019-01-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07255547","publication_url":"https://clinicaltrials.gov/study/NCT07255547","title":"Arthrosocpic Treatment of Knee Chondral Lesions: Clinical, MRI and Histologic Comparison Between the Use of PRP vs ADSCs in Addition to Marrow Stimulation Techniques","has_exemption":false,"start_date":"2019-05-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Università degli Studi dell'Aquila","sponsor_slug":"universita-degli-studi-dellaquila","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03933735","publication_url":"https://clinicaltrials.gov/study/NCT03933735","title":"A Multicenter, Phase 1, Open-label, Dose-escalation and Expansion Study of TNB-383B, a Bispecific Antibody Targeting BCMA in Subjects With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2019-06-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04175041","publication_url":"https://clinicaltrials.gov/study/NCT04175041","title":"A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC","has_exemption":false,"start_date":"2019-07-09","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04082533","publication_url":"https://clinicaltrials.gov/study/NCT04082533","title":"Effect of Intravenous Hydrocortisone on Range of Motion After Total Knee Arthroplasty: A Randomized Placebo-Controlled Trial With Nested Case-Control Study","has_exemption":false,"start_date":"2019-07-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04002947","publication_url":"https://clinicaltrials.gov/study/NCT04002947","title":"A Phase 2 Study of Acalabrutinib With DA-EPOCH-R or R-CHOP for Patients With Untreated Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2019-08-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04100148","publication_url":"https://clinicaltrials.gov/study/NCT04100148","title":"SyncAV Post-Market Trial","has_exemption":false,"start_date":"2019-10-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03987763","publication_url":"https://clinicaltrials.gov/study/NCT03987763","title":"A Phase 4, Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-122 Lotion in Pediatric Subjects With Moderate to Severe Plaque Psoriasis","has_exemption":false,"start_date":"2019-10-22","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03841097","publication_url":"https://clinicaltrials.gov/study/NCT03841097","title":"A Phase IV, Prospective, Randomized, Open-label, Comparative Analysis, Single-center Study of Pulse Wave Velocity Evaluation, Tacrolimus TTR and Co-efficient of Tacrolimus Variation of African American Kidney Recipients Receiving Standard of Care Immediate Release Tacrolimus Capsules or Extended Release Tacrolimus Tablets","has_exemption":false,"start_date":"2019-11-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Roy D. Bloom, MD","sponsor_slug":"roy-d-bloom-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04180579","publication_url":"https://clinicaltrials.gov/study/NCT04180579","title":"Safety and Tolerability of Lower Scalp Cooling Temperatures to Prevent Doxorubicin Plus Cyclophosphamide and Paclitaxel-induced Alopecia in Breast Cancer Patients","has_exemption":false,"start_date":"2019-11-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04084080","publication_url":"https://clinicaltrials.gov/study/NCT04084080","title":"Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)","has_exemption":false,"start_date":"2020-02-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Pittsburgh","sponsor_slug":"university-of-pittsburgh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04374461","publication_url":"https://clinicaltrials.gov/study/NCT04374461","title":"Phase II Study of N-acetylcysteine in Severe or Critically Ill Patients With Refractory COVID-19 Infection","has_exemption":false,"start_date":"2020-05-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04400292","publication_url":"https://clinicaltrials.gov/study/NCT04400292","title":"Does the Concept of the Sentinel Lymph Node Apply to Esophageal Cancer? A Prospective Assessment of Near-infrared Image-guided Lymphatic Mapping and Sentinel Lymph Node Identification in Esophageal Cancer","has_exemption":false,"start_date":"2020-05-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04410796","publication_url":"https://clinicaltrials.gov/study/NCT04410796","title":"A Phase 2 Randomized Study of Osimertinib Versus Osimertinib Plus Chemotherapy for Patients With Metastatic EGFR-Mutant Lung Cancers That Have Detectable EGFR-Mutant cfDNA in Plasma After Initiation of Osimertinib","has_exemption":false,"start_date":"2020-05-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04360330","publication_url":"https://clinicaltrials.gov/study/NCT04360330","title":"Phase I Study to Evaluate the Safety and Feasibility of Preoperative Ablative Breast Radiotherapy (SABER) for Selected Early Stage Breast Cancer","has_exemption":false,"start_date":"2020-08-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04122001","publication_url":"https://clinicaltrials.gov/study/NCT04122001","title":"Transcranial Direct Current Stimulation in Typical and Atypical Alzheimer's Disease","has_exemption":false,"start_date":"2020-08-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04624698","publication_url":"https://clinicaltrials.gov/study/NCT04624698","title":"iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study","has_exemption":false,"start_date":"2020-09-22","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04576793","publication_url":"https://clinicaltrials.gov/study/NCT04576793","title":"Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease","has_exemption":false,"start_date":"2020-11-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Patrick Lao","sponsor_slug":"patrick-lao","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04506554","publication_url":"https://clinicaltrials.gov/study/NCT04506554","title":"A Phase II Trial of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer","has_exemption":false,"start_date":"2020-12-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04626479","publication_url":"https://clinicaltrials.gov/study/NCT04626479","title":"A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (U03): Substudy 03A in First Line Metastatic Participants","has_exemption":false,"start_date":"2020-12-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04626518","publication_url":"https://clinicaltrials.gov/study/NCT04626518","title":"A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (KEYMAKER-U03): Substudy 03B in Second-Line Metastatic Participants","has_exemption":false,"start_date":"2020-12-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565015","publication_url":"https://clinicaltrials.gov/study/NCT04565015","title":"An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency","has_exemption":false,"start_date":"2020-12-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"GC Biopharma Corp","sponsor_slug":"gc-biopharma-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03926520","publication_url":"https://clinicaltrials.gov/study/NCT03926520","title":"Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia","has_exemption":false,"start_date":"2021-01-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Brent Forester","sponsor_slug":"brent-forester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04727242","publication_url":"https://clinicaltrials.gov/study/NCT04727242","title":"Phase 2 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Gemcitabine Followed by Systemic Adjuvant Chemotherapy With Dacarbazine for Locally Recurrent Uterine Leiomyosarcoma (LMS)","has_exemption":false,"start_date":"2021-01-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04782947","publication_url":"https://clinicaltrials.gov/study/NCT04782947","title":"Epidural Stimulation and Resistance Training for Overground Locomotion After Spinal Cord Injury","has_exemption":false,"start_date":"2021-02-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"United States Department of Defense","sponsor_slug":"united-states-department-of-defense","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04598009","publication_url":"https://clinicaltrials.gov/study/NCT04598009","title":"A Phase II Study of Binimetinib in Combination With Imatinib in Patients With Advanced KIT-Mutant Melanoma","has_exemption":false,"start_date":"2021-03-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04790344","publication_url":"https://clinicaltrials.gov/study/NCT04790344","title":"LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study (LUX-Dx TRENDS)","has_exemption":false,"start_date":"2021-03-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04817007","publication_url":"https://clinicaltrials.gov/study/NCT04817007","title":"A Phase 1b/2 Study of BMS-986158 Monotherapy and in Combination With Either Ruxolitinib or Fedratinib in Participants With DIPSS-Intermediate or High Risk Myelofibrosis","has_exemption":false,"start_date":"2021-03-22","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05044468","publication_url":"https://clinicaltrials.gov/study/NCT05044468","title":"A Randomized Blinded Controlled Trial of EXPAREL vs 1% Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement","has_exemption":false,"start_date":"2021-03-23","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04101838","publication_url":"https://clinicaltrials.gov/study/NCT04101838","title":"B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04905316","publication_url":"https://clinicaltrials.gov/study/NCT04905316","title":"Phase I/II Study of Canakinumab With Chemoradiation and Durvalumab for Unresected Locally-Advanced Non-Small Cell Lung Cancer (CHORUS)","has_exemption":false,"start_date":"2021-05-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04606914","publication_url":"https://clinicaltrials.gov/study/NCT04606914","title":"Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Are Folate Receptor α Positive","has_exemption":false,"start_date":"2021-05-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04748042","publication_url":"https://clinicaltrials.gov/study/NCT04748042","title":"Focal Radiation With Pulsed Systemic Therapy of Abiraterone, ADT, Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON): A Phase II, Single Arm, Single Institution Study","has_exemption":false,"start_date":"2021-05-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04496349","publication_url":"https://clinicaltrials.gov/study/NCT04496349","title":"A Phase IIa Study Evaluating the Pharmacokinetics, Safety and Efficacy of APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With Relapsed/Refractory T-Cell Prolymphocytic Leukemia (R/R T-PLL) or Non-Hodgkin's Lymphoma (NHL).","has_exemption":false,"start_date":"2021-07-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Ascentage Pharma Group Inc.","sponsor_slug":"ascentage-pharma-group-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04625127","publication_url":"https://clinicaltrials.gov/study/NCT04625127","title":"GaitBetter: Motor and Cognitive Training for Gait Rehabilitation and Falls Prevention in Stroke Survivors.","has_exemption":false,"start_date":"2021-07-23","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04786093","publication_url":"https://clinicaltrials.gov/study/NCT04786093","title":"Randomized Phase II Study of Durvalumab (MEDI 4736) and Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2021-07-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04836390","publication_url":"https://clinicaltrials.gov/study/NCT04836390","title":"A Phase II Pilot Study of Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant: A Multicenter Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) Study","has_exemption":false,"start_date":"2021-08-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Michael Pulsipher","sponsor_slug":"michael-pulsipher","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04782687","publication_url":"https://clinicaltrials.gov/study/NCT04782687","title":"A Phase II Trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in Combination With Selinexor for Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2021-09-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"US Oncology Research","sponsor_slug":"us-oncology-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04975919","publication_url":"https://clinicaltrials.gov/study/NCT04975919","title":"A Phase II Study of Venetoclax in Combination With 10-day Oral Decitabine in Relapsed/Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2021-09-29","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05101096","publication_url":"https://clinicaltrials.gov/study/NCT05101096","title":"A Phase 1/2 Open-Label Study of Sacituzumab Govitecan in Japanese Patients With Advanced Solid Tumors (ASCENT-J02)","has_exemption":false,"start_date":"2021-10-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04712097","publication_url":"https://clinicaltrials.gov/study/NCT04712097","title":"Phase III Randomized, Open-Label, Multicenter Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a Non-Randomized Single Arm US Extension of Mosunetuzumab in Combination With Lenalidomide in Patients With Follicular Lymphoma After at Least One Line of Systemic Therapy","has_exemption":false,"start_date":"2021-10-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05144854","publication_url":"https://clinicaltrials.gov/study/NCT05144854","title":"A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab, Fluoropyrimidine-based and Platinum-based Chemotherapy (Hereinafter Referred to as \"Chemotherapy\") Versus Chemotherapy in Chemotherapy-naïve Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)","has_exemption":false,"start_date":"2021-11-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Ono Pharmaceutical Co. Ltd","sponsor_slug":"ono-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04794530","publication_url":"https://clinicaltrials.gov/study/NCT04794530","title":"COCOA Flavanols to Improve Walking Performance in PAD: the COCOA-PAD II Trial","has_exemption":false,"start_date":"2021-11-19","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04862650","publication_url":"https://clinicaltrials.gov/study/NCT04862650","title":"A Phase II Trial of the Efficacy and Safety of the Combination of Cemiplimab and Low-Dose Paclitaxel and Carboplatin in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2021-11-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Marcelo Bonomi","sponsor_slug":"marcelo-bonomi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05123755","publication_url":"https://clinicaltrials.gov/study/NCT05123755","title":"A Randomized, Double-blind, Placebo-controlled, Phase 2a Multiple Ascending Dose Study to Examine the Safety, Tolerability and Efficacy of AV-001 Injection in Patients Hospitalized With Pneumonia Due To COVID-19 or Other Respiratory Infections.","has_exemption":false,"start_date":"2021-12-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vasomune Therapeutics, Inc.","sponsor_slug":"vasomune-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04891068","publication_url":"https://clinicaltrials.gov/study/NCT04891068","title":"BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer","has_exemption":false,"start_date":"2022-01-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05218187","publication_url":"https://clinicaltrials.gov/study/NCT05218187","title":"Robotic Gait Rehabilitation in Parkinson's Disease","has_exemption":false,"start_date":"2022-01-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05125302","publication_url":"https://clinicaltrials.gov/study/NCT05125302","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-attack Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17)","has_exemption":false,"start_date":"2022-01-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04577859","publication_url":"https://clinicaltrials.gov/study/NCT04577859","title":"Improving Esophageal Protection During AF Ablation: a Multicenter Double-blind Randomized Clinical Trial","has_exemption":false,"start_date":"2022-03-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Advanced Cooling Therapy LLC, d/b/a Attune Medical","sponsor_slug":"advanced-cooling-therapy-llc-dba-attune-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05168618","publication_url":"https://clinicaltrials.gov/study/NCT05168618","title":"AtezoCab: A Phase II Study of Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Non-Measurable Disease","has_exemption":false,"start_date":"2022-03-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05309551","publication_url":"https://clinicaltrials.gov/study/NCT05309551","title":"The Effects of Inspiratory Muscle Training Immediatley After Lung Transplantation: a Randomized Controlled Trial","has_exemption":false,"start_date":"2022-04-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05328934","publication_url":"https://clinicaltrials.gov/study/NCT05328934","title":"Toward Use of the Synergy-based SoftHand Pro for Activities of Daily Living by Persons With Transradial Limb Loss: A Multi-site Clinical Trial","has_exemption":false,"start_date":"2022-04-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05329649","publication_url":"https://clinicaltrials.gov/study/NCT05329649","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Severe Sickle Cell Disease","has_exemption":false,"start_date":"2022-05-02","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05356195","publication_url":"https://clinicaltrials.gov/study/NCT05356195","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Transfusion-Dependent β-Thalassemia","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04629547","publication_url":"https://clinicaltrials.gov/study/NCT04629547","title":"Sleep Trial to Prevent Alzheimer's Disease","has_exemption":false,"start_date":"2022-05-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05356104","publication_url":"https://clinicaltrials.gov/study/NCT05356104","title":"GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) - A Pilot Study","has_exemption":false,"start_date":"2022-05-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05345444","publication_url":"https://clinicaltrials.gov/study/NCT05345444","title":"Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)","has_exemption":false,"start_date":"2022-05-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05292001","publication_url":"https://clinicaltrials.gov/study/NCT05292001","title":"Role of Single-dose Intravenous Iron Therapy for the Treatment of Anemia in the Setting of Orthopaedic Trauma: a Pilot Study","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05354232","publication_url":"https://clinicaltrials.gov/study/NCT05354232","title":"Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05113537","publication_url":"https://clinicaltrials.gov/study/NCT05113537","title":"Phase I/II Study of CDK4/6 Inhibition With Abemaciclib to Upregulate PSMA Expression Prior to 177Lu-PSMA-617 Treatment in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Chemotherapy","has_exemption":false,"start_date":"2022-07-08","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vadim S Koshkin","sponsor_slug":"vadim-s-koshkin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04796285","publication_url":"https://clinicaltrials.gov/study/NCT04796285","title":"A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor","has_exemption":false,"start_date":"2022-08-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05520359","publication_url":"https://clinicaltrials.gov/study/NCT05520359","title":"Transcutaneous Stimulation and Mobility Device Use for Individuals With Neurologic Conditions","has_exemption":false,"start_date":"2022-08-04","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04839705","publication_url":"https://clinicaltrials.gov/study/NCT04839705","title":"Post-Approval Study - Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the WEB Device","has_exemption":false,"start_date":"2022-08-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Microvention-Terumo, Inc.","sponsor_slug":"microvention-terumo-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05425940","publication_url":"https://clinicaltrials.gov/study/NCT05425940","title":"A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-09-07","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Exelixis","sponsor_slug":"exelixis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05763602","publication_url":"https://clinicaltrials.gov/study/NCT05763602","title":"Intranasal Povidone Iodine (PVI) to Prevent Staphylococcus Aureus Surgical Site Infections After Operative Procedures to Fix High-Energy Lower Extremity Fractures (POTENT Study)","has_exemption":false,"start_date":"2022-09-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Loreen Herwaldt","sponsor_slug":"loreen-herwaldt","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05339126","publication_url":"https://clinicaltrials.gov/study/NCT05339126","title":"RNS System Feasibility Study of Thalamocortical Brain-Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome","has_exemption":false,"start_date":"2022-10-04","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"NeuroPace","sponsor_slug":"neuropace","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05546268","publication_url":"https://clinicaltrials.gov/study/NCT05546268","title":"A Phase 1/2 Study of Oral MRT-2359 in Patients With MYC-Driven and Other Selected Solid Tumors Including Lung Cancer and Diffuse B-Cell Lymphoma","has_exemption":false,"start_date":"2022-10-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Monte Rosa Therapeutics, Inc","sponsor_slug":"monte-rosa-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05426525","publication_url":"https://clinicaltrials.gov/study/NCT05426525","title":"Use of Empagliflozin to Treat Prediabetes - a Randomized, Double-blind, Placebo-controlled 13-week Intervention Trial","has_exemption":false,"start_date":"2022-10-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Oregon State University","sponsor_slug":"oregon-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05478213","publication_url":"https://clinicaltrials.gov/study/NCT05478213","title":"Ventricular Tachycardia Substrate Mechanisms Revealed by Local Repolarization and Conduction Parameters","has_exemption":false,"start_date":"2022-10-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05354947","publication_url":"https://clinicaltrials.gov/study/NCT05354947","title":"Effects of Multi-Site Abdominal Ultrasound Stimulation on Glycemic Control in T2DM","has_exemption":false,"start_date":"2022-11-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05384847","publication_url":"https://clinicaltrials.gov/study/NCT05384847","title":"Effects of Triiodothyronine (T3) in Ischemic Heart Failure","has_exemption":false,"start_date":"2022-12-02","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531526","publication_url":"https://clinicaltrials.gov/study/NCT05531526","title":"A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 Over 52 Weeks in Participants With Early Alzheimer's Disease (Polaris-AD)","has_exemption":false,"start_date":"2022-12-23","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AriBio Co., Ltd.","sponsor_slug":"aribio-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05645107","publication_url":"https://clinicaltrials.gov/study/NCT05645107","title":"A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® Plus Standard Medical Treatment Compared to Placebo Plus Standard Medical Treatment to Prevent Infections in Patients With Hypogammaglobulinemia and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-12-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05551936","publication_url":"https://clinicaltrials.gov/study/NCT05551936","title":"A Single Arm Phase I/II Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma Big Ten Cancer Research Consortium BTCRC-LYM20-463","has_exemption":false,"start_date":"2023-01-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vaishalee Kenkre","sponsor_slug":"vaishalee-kenkre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05127915","publication_url":"https://clinicaltrials.gov/study/NCT05127915","title":"A Prospective, Multicenter, Pivotal Study With Randomized Controlled Prophylactic and Independent Therapeutic Cohorts to Evaluate the Safety and Efficacy of an Absorbable Vena Cava Filter for Pulmonary Embolism Prevention","has_exemption":false,"start_date":"2023-01-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Adient Medical","sponsor_slug":"adient-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05686551","publication_url":"https://clinicaltrials.gov/study/NCT05686551","title":"A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals With Prodromal and Early Manifest Huntington's Disease","has_exemption":false,"start_date":"2023-02-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04661995","publication_url":"https://clinicaltrials.gov/study/NCT04661995","title":"Notched Noise Therapy for Suppression of Tinnitus: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05830110","publication_url":"https://clinicaltrials.gov/study/NCT05830110","title":"Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Synergic Medical Technologies, Inc.","sponsor_slug":"synergic-medical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05556824","publication_url":"https://clinicaltrials.gov/study/NCT05556824","title":"A Multi-Center Study of Panosyl-Isomaltooligosaccharides (PIMO) Adjunctive to Proton Pump Inhibitor (PPI) Therapy to Treat Gastroesophageal Reflux Disease (GERD) in Subjects Who Are PPI-Responders or PPI-Partial Responders","has_exemption":false,"start_date":"2023-03-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Microbiome Health Sciences","sponsor_slug":"microbiome-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05604222","publication_url":"https://clinicaltrials.gov/study/NCT05604222","title":"Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women","has_exemption":false,"start_date":"2023-03-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Shachi Tyagi","sponsor_slug":"shachi-tyagi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05700942","publication_url":"https://clinicaltrials.gov/study/NCT05700942","title":"Transcutaneous Spinal Direct Current Stimulation to Enhance Locomotor Rehabilitation After Spinal Cord Injury","has_exemption":false,"start_date":"2023-03-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05741333","publication_url":"https://clinicaltrials.gov/study/NCT05741333","title":"Pivotal In-Office Clinical Study of the Solo+ Tympanostomy Tube Device","has_exemption":false,"start_date":"2023-03-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AventaMed DAC","sponsor_slug":"aventamed-dac","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05654922","publication_url":"https://clinicaltrials.gov/study/NCT05654922","title":"A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung Transplant","has_exemption":false,"start_date":"2023-04-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Renovion, Inc.","sponsor_slug":"renovion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05593588","publication_url":"https://clinicaltrials.gov/study/NCT05593588","title":"Senolytics as a Novel Treatment for Interstitial Lung Disease in Common Variable Immunodeficiency (CVID)","has_exemption":false,"start_date":"2023-04-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Avni Joshi","sponsor_slug":"avni-joshi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05597878","publication_url":"https://clinicaltrials.gov/study/NCT05597878","title":"Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-04-18","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05765175","publication_url":"https://clinicaltrials.gov/study/NCT05765175","title":"Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia","has_exemption":false,"start_date":"2023-04-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05723055","publication_url":"https://clinicaltrials.gov/study/NCT05723055","title":"A Proof-of-Concept Multicenter Trial Evaluating Response Adapted Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma","has_exemption":false,"start_date":"2023-05-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05642572","publication_url":"https://clinicaltrials.gov/study/NCT05642572","title":"A Randomized Phase II Study of INC280 (Capmatinib) Plus Osimertinib With or Without Ramucirumab in Participants With EGFR-Mutant, MET-Amplified Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)","has_exemption":false,"start_date":"2023-05-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05851924","publication_url":"https://clinicaltrials.gov/study/NCT05851924","title":"Total Neoadjuvant NALIRIFOX Plus Ablative Dose Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2023-05-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05732831","publication_url":"https://clinicaltrials.gov/study/NCT05732831","title":"A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 as a Single Agent and in Combination in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-05-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Tango Therapeutics, Inc.","sponsor_slug":"tango-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05914831","publication_url":"https://clinicaltrials.gov/study/NCT05914831","title":"Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI): A Single-Institution Prospective Phase 2 Trial","has_exemption":false,"start_date":"2023-06-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Oncology Institute of Vojvodina","sponsor_slug":"oncology-institute-of-vojvodina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05893498","publication_url":"https://clinicaltrials.gov/study/NCT05893498","title":"Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment","has_exemption":false,"start_date":"2023-06-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"CathWorks Ltd.","sponsor_slug":"cathworks-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05526001","publication_url":"https://clinicaltrials.gov/study/NCT05526001","title":"A Phase III, Randomized, Parallel, Double-blinding, 2-Arm Study to Investigate the Efficacy and Safety of Intra-articular ELIXCYTE (Adipose-Derived Stem Cells) Injection Compared With Placebo in Subjects With Knee Osteoarthritis","has_exemption":false,"start_date":"2023-07-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"UnicoCell Biomed CO. LTD","sponsor_slug":"unicocell-biomed-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05710848","publication_url":"https://clinicaltrials.gov/study/NCT05710848","title":"A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer","has_exemption":false,"start_date":"2023-07-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"SURGE Therapeutics","sponsor_slug":"surge-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05929079","publication_url":"https://clinicaltrials.gov/study/NCT05929079","title":"A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2023-07-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05874414","publication_url":"https://clinicaltrials.gov/study/NCT05874414","title":"Phase 1b/2a Study of GNS561 in Combination With Trametinib in Advanced KRAS Mutated Cholangiocarcinoma","has_exemption":false,"start_date":"2023-08-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Genfit","sponsor_slug":"genfit","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05999851","publication_url":"https://clinicaltrials.gov/study/NCT05999851","title":"Multiparametric Assessment of Maternal Vascular Function as a New Diagnostic and Prognostic Tool for Hypertensive Disorders of Pregnancy and Preeclampsia - EDIPE Study","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","sponsor_slug":"irccs-azienda-ospedaliero-universitaria-di-bologna","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05797805","publication_url":"https://clinicaltrials.gov/study/NCT05797805","title":"A Phase 1/2 Exploratory Study of the TBL1 Inhibitor, Tegavivint (BC2059), in Patients With Advanced Hepatocellular Carcinoma","has_exemption":false,"start_date":"2023-09-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Iterion Therapeutics","sponsor_slug":"iterion-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05794139","publication_url":"https://clinicaltrials.gov/study/NCT05794139","title":"A Phase 2, Randomised, Double-blind, Placebo-controlled, 2-way Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 in Ambulatory Adults With Type 3 Spinal Muscular Atrophy","has_exemption":false,"start_date":"2023-09-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"NMD Pharma A/S","sponsor_slug":"nmd-pharma-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05794321","publication_url":"https://clinicaltrials.gov/study/NCT05794321","title":"Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy","has_exemption":false,"start_date":"2023-09-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05867329","publication_url":"https://clinicaltrials.gov/study/NCT05867329","title":"A Sequential Multiple Assignment Randomized Trial (SMART) Feasibility Pilot Developing and Optimizing Patient-Tailored Adaptive Treatment Strategies (ATS) for Acute Severe Ulcerative Colitis (ASUC)","has_exemption":false,"start_date":"2023-09-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Berinstein, Jeffrey","sponsor_slug":"berinstein-jeffrey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06087653","publication_url":"https://clinicaltrials.gov/study/NCT06087653","title":"A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration of Low-dose Lenalidomide (STAR-LLD) for the Treatment of Multiple Myeloma (MM)","has_exemption":false,"start_date":"2023-10-02","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Starton Therapeutics, Inc","sponsor_slug":"starton-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06075667","publication_url":"https://clinicaltrials.gov/study/NCT06075667","title":"Efficacy, Safety, and Pharmacokinetics of Tirzepatide Once Weekly Versus Placebo in Adolescent Participants Who Have Obesity, or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind Trial (SURMOUNT-ADOLESCENTS)","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915922","publication_url":"https://clinicaltrials.gov/study/NCT06915922","title":"Therapeutic Neodymium-doped Yttrium-Aluminum-Garnet (Nd:YAG) Laser Vitreolysis for Vitreous Floaters - A Study to Quantify Visual Quality of Life, Vitreous Structure, and Vision Before and After Nd:YAG Laser Vitreolysis in Patients With Vision Degrading Myodesopsia","has_exemption":false,"start_date":"2023-10-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"VMR Consulting, Inc.","sponsor_slug":"vmr-consulting-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938465","publication_url":"https://clinicaltrials.gov/study/NCT05938465","title":"A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis (PROF). The \"PROF\" Study.","has_exemption":false,"start_date":"2023-11-06","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Exegi Pharma, LLC","sponsor_slug":"exegi-pharma-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05758688","publication_url":"https://clinicaltrials.gov/study/NCT05758688","title":"Adjuvant Proton Whole Pelvis Radiation Therapy for Treatment of Post-Surgical Gynecologic Cancers","has_exemption":false,"start_date":"2023-11-06","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003231","publication_url":"https://clinicaltrials.gov/study/NCT06003231","title":"A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects With Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2","has_exemption":false,"start_date":"2023-11-14","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05784246","publication_url":"https://clinicaltrials.gov/study/NCT05784246","title":"A Multicenter, Phase 3, Open-Label Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2023-11-22","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06058377","publication_url":"https://clinicaltrials.gov/study/NCT06058377","title":"Phase III Trial Of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone For Adults With MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer","has_exemption":false,"start_date":"2023-11-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06489431","publication_url":"https://clinicaltrials.gov/study/NCT06489431","title":"Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement: A Prospective Non-inferiority Trial","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06165419","publication_url":"https://clinicaltrials.gov/study/NCT06165419","title":"A Phase II Study Evaluating Definitive Radiosurgical Decompression in Patients With High-Risk Spinal Metastases","has_exemption":false,"start_date":"2023-12-14","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948475","publication_url":"https://clinicaltrials.gov/study/NCT05948475","title":"A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib VS Physician's Choice in Subjects With FGFR-altered, Chemotherapy- and FGFR Inhibitor-Cholangiocarcinoma","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"TransThera Sciences (Nanjing), Inc.","sponsor_slug":"transthera-sciences-nanjing-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06017609","publication_url":"https://clinicaltrials.gov/study/NCT06017609","title":"A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of JTT-861 Administered for 12 Weeks in Subjects With Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Akros Pharma Inc.","sponsor_slug":"akros-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06058013","publication_url":"https://clinicaltrials.gov/study/NCT06058013","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Neumora Therapeutics, Inc.","sponsor_slug":"neumora-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06058039","publication_url":"https://clinicaltrials.gov/study/NCT06058039","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Neumora Therapeutics, Inc.","sponsor_slug":"neumora-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776641","publication_url":"https://clinicaltrials.gov/study/NCT05776641","title":"Prevention of Alzheimer's Disease Using Gamma Entrainment","has_exemption":false,"start_date":"2024-01-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05558358","publication_url":"https://clinicaltrials.gov/study/NCT05558358","title":"Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder","has_exemption":false,"start_date":"2024-01-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06018337","publication_url":"https://clinicaltrials.gov/study/NCT06018337","title":"A Phase 3, Randomized, Multi-center, Open-Label Study of DB-1303 Versus Investigator's Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients Whose Disease Has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02)","has_exemption":false,"start_date":"2024-01-18","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05864534","publication_url":"https://clinicaltrials.gov/study/NCT05864534","title":"A Phase 2a Trial of Immune Modulation in Combination With Ultrasound-mediated Blood Brain Barrier Opening in Patients With Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2024-01-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05762055","publication_url":"https://clinicaltrials.gov/study/NCT05762055","title":"Prospective Comparative Analysis Evaluating Radiographic and Clinical Outcomes of Stand-Alone Anterior Cervical Discectomy and Fusion Interbody Cages With nanoLOCK Osseointegrative Technology","has_exemption":false,"start_date":"2024-02-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06266494","publication_url":"https://clinicaltrials.gov/study/NCT06266494","title":"Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06232577","publication_url":"https://clinicaltrials.gov/study/NCT06232577","title":"5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-03-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06170450","publication_url":"https://clinicaltrials.gov/study/NCT06170450","title":"CYclic Versus Continuous Sacral Modulation for LowEr Urinary Tract Symptoms: a Prospective Randomized Controlled Trial (CYCLE Trial)","has_exemption":false,"start_date":"2024-04-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06228235","publication_url":"https://clinicaltrials.gov/study/NCT06228235","title":"Optimizing the rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings","has_exemption":false,"start_date":"2024-04-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06263452","publication_url":"https://clinicaltrials.gov/study/NCT06263452","title":"Beta-Blocker Influences on Inflammatory and Neural Responses to Stress","has_exemption":false,"start_date":"2024-05-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05800210","publication_url":"https://clinicaltrials.gov/study/NCT05800210","title":"Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases","has_exemption":false,"start_date":"2024-05-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06309966","publication_url":"https://clinicaltrials.gov/study/NCT06309966","title":"A Phase 2/3 Multicenter, Randomization, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy","has_exemption":false,"start_date":"2024-05-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055439","publication_url":"https://clinicaltrials.gov/study/NCT06055439","title":"A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 (CDH17) Chimeric Antigen Receptor (CAR) T Cell Therapy for the Treatment of Relapsed or Refractory Gastrointestinal Cancers","has_exemption":false,"start_date":"2024-05-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Chimeric Therapeutics","sponsor_slug":"chimeric-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06414954","publication_url":"https://clinicaltrials.gov/study/NCT06414954","title":"A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 3 Dose Levels of NMD670 Over 21 Days in Adult Patients With AChR/MuSK-Ab+ Myasthenia Gravis","has_exemption":false,"start_date":"2024-05-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"NMD Pharma A/S","sponsor_slug":"nmd-pharma-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06347133","publication_url":"https://clinicaltrials.gov/study/NCT06347133","title":"Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Hypertriglyceridemia","has_exemption":false,"start_date":"2024-05-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Arrowhead Pharmaceuticals","sponsor_slug":"arrowhead-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111768","publication_url":"https://clinicaltrials.gov/study/NCT06111768","title":"Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study","has_exemption":false,"start_date":"2024-05-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284824","publication_url":"https://clinicaltrials.gov/study/NCT06284824","title":"Prospective, Randomized, Single-center Study Comparing the Stryker MAKO™ Robotic-Arm Assisted Total Knee Arthroplasty and the DePuy VELYS™ Robotic-Assisted Solution for Total Knee Arthroplasty.","has_exemption":false,"start_date":"2024-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Southeast Orthopedic Specialists","sponsor_slug":"southeast-orthopedic-specialists","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06170606","publication_url":"https://clinicaltrials.gov/study/NCT06170606","title":"Prospective Multi-Site Safety and Effectiveness Study of the Boston Scientific Cardiac Cryoablation System for Drug Refractory, Recurrent Symptomatic Paroxysmal Atrial Fibrillation","has_exemption":false,"start_date":"2024-06-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06400004","publication_url":"https://clinicaltrials.gov/study/NCT06400004","title":"A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason® in Patients With Suboptimal Unenhanced Echocardiography","has_exemption":false,"start_date":"2024-07-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Bracco Diagnostics, Inc","sponsor_slug":"bracco-diagnostics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462612","publication_url":"https://clinicaltrials.gov/study/NCT06462612","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)","has_exemption":false,"start_date":"2024-07-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06538116","publication_url":"https://clinicaltrials.gov/study/NCT06538116","title":"A Randomized, Double-Blinded Study to Evaluate the Efficacy and Safety of Mevidalen in Patients With Alzheimer's Disease","has_exemption":false,"start_date":"2024-08-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580873","publication_url":"https://clinicaltrials.gov/study/NCT06580873","title":"Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)","has_exemption":false,"start_date":"2024-09-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Saskatchewan Health Authority - Regina Area","sponsor_slug":"saskatchewan-health-authority-regina-area","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919042","publication_url":"https://clinicaltrials.gov/study/NCT06919042","title":"A Prospective Single-center Study for Evaluation of the Effectiveness of Pulsed Acoustic Cellular Expression Technology on Post-Operative Soft Tissue Fibrosis.","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06519955","publication_url":"https://clinicaltrials.gov/study/NCT06519955","title":"Peri-incisional Local Infiltration to Improve Pain Control After Periacetabular Osteotomy","has_exemption":false,"start_date":"2024-10-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Michael C Willey","sponsor_slug":"michael-c-willey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06513312","publication_url":"https://clinicaltrials.gov/study/NCT06513312","title":"A Phase 2, Open-label, Multicenter, Randomized Study to Evaluate the Persistence, Safety, Acceptability, and Pharmacokinetics of Twice Yearly Long-acting Subcutaneous Lenacapavir for HIV Pre-Exposure Prophylaxis (PrEP) in People Who Would Benefit From PrEP","has_exemption":false,"start_date":"2024-10-07","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null}]}